✦ LIBER ✦

A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)

✍ Scribed by Cognetti, F.; Bagnato, A.; Colombo, N.; Savarese, A.; Scambia, G.; Sehouli, J.; Wimberger, P.; Sorio, R.; Harter, P.; Mari, E.; McIntosh, S.; Nathan, F.; Pemberton, K.; Baumann, K.

Book ID: 125432866
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 310 KB
Volume: 130
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.12.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase II study evaluating t

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

✍ Kaye, S. B.; Poole, C. J.; Danska-Bidzinska, A.; Gianni, L.; Del Conte, G.; Gorb 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 251 KB

Randomized, Phase II, Placebo-Controlled

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer

✍ Vergote, Ignace B. (author);Amant, Frederic (author);Chekerov, Radoslav (author) 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

Randomized, Phase II, Placebo-Controlled

✍ Vergote, Ignace B. (author);Amant, Frederic (author);Chekerov, Radoslav (author) 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

Neuroprotection with amifostine in the f

Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group

✍ F. Hilpert; A. Stähle; O. Tomé; A. Burges; D. Rossner; K. Späthe; V. Heilmann; B 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

9007 Randomized, double-blind phase II/I

9007 Randomized, double-blind phase II/III study of first-line paclitaxel (P) plus carboplatin (C) in combination with vorinostat or placebo in patients with advanced non-small-cell lung cancer (NSCLC)

✍ Belani, C.; Ramalingam, S.; Kalemkerian, G.; Mok, T.; Rosell, R.; Ahn, M.J.; Sun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

38 Influence of amifostine on neuroprote

38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group

✍ P. Wimberger; R. Kimmig; F. Hilpert; A. Stähle; A. Burges; O. Tomé; D. Rossner; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 327 KB